piperazineProperties:
RelatedCategories | AnalyticalStandards,Analytical/Chromatography,EPStandards,EPStandardsI-K,Pharmacopeia&MetrologicalInstitutesStandards |
Description:
Application
CYP3A4inhibitor
Biochem/physiolActions
Antifungalagent
Caution
PleasefindSDSprovidedbyEDQMhere.
.
Generaldescription
ThisproductisprovidedasdeliveredandspecifiedbytheissuingPharmacopoeia.Allinformationprovidedinsupportofthisproduct,includingSDSandanyproductinformationleafletshavebeendevelopedandissuedundertheAuthorityoftheIssuingPharmacopoeia.ForfurtherinformationandsupportpleasegotothewebsiteoftheissuingPharmacopoeia
.
OtherNotes
Salesrestrictionsmayapply.
Packaging
Unitquantity:150mg.Subjecttochange.TheproductisdeliveredassuppliedbytheissuingPharmacopoeia.Forthecurrentunitquantity,pleasevisittheEDQMreferencesubtancecatalogue
.
Safety:
Hazardstatements
H301-H360F-H373-H410
Precautionarystatements
MissingPhrase-N15.00950417-P201-P260-P280-P308+P313
RIDADR
UN2811-class6.1-PG3-EHS-Toxicsolids,organic,n.o.s.,HI:all